Related Experiment Video
Updated: Jul 5, 2026
12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
T-regulatory cells in systemic lupus erythematosus
1Division of Rheumatology, Department of Medicine, University of California Los Angeles, Los Angeles, California 90095-1670, USA. alacava@mednet.ucla.edu
Lupus
|May 21, 2008
Summary
Regulatory T-cells (Tregs) are crucial for immune tolerance. This review explores their role in systemic lupus erythematosus (SLE), highlighting potential therapeutic strategies targeting Tregs for disease management.
Area of Science:
- Immunology
- Autoimmunity
- Cellular immunology
Background:
- T-regulatory cells (Tregs), specifically thymus-derived CD4(+)CD25(high)Foxp3(+), are vital for peripheral immune tolerance.
- Tregs prevent autoimmunity by suppressing effector immune cell proliferation and pro-inflammatory cytokine production.
- Reduced circulating Tregs in systemic lupus erythematosus (SLE) may correlate with disease activity and severity.
Purpose of the Study:
- To review the current understanding of the role of Tregs in SLE.
- To discuss recent findings regarding Treg modulation for SLE treatment.
- To explore the potential of Treg-based interventions in managing lupus.
Main Methods:
- Literature review of studies on Tregs and SLE.
- Analysis of data from murine lupus models.
- Discussion of emerging therapeutic strategies targeting Tregs.
Main Results:
- Evidence suggests a decrease in circulating Tregs during active SLE, linked to disease severity.
- Murine lupus models indicate that targeting Tregs can modulate SLE.
- Treg-based interventions show promise as a novel therapeutic approach for SLE.
Conclusions:
- Tregs play a significant role in the immune dysregulation observed in SLE.
- Targeting Tregs presents a promising avenue for novel SLE immunomodulatory therapies.
- Further research into Treg-based interventions could lead to improved SLE management.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:28Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...